Search for the latest oncology news by tumour type
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…
A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage…
The KEYNOTE-062 phase III randomised clinical trial achieved its primary endpoint, showing that for patients…
The international, randomised phase III MONALEESA-7 trial found that adding ribociclib to standard-of-care endocrine therapy…
Five-year data from the phase Ib KEYNOTE-001 clinical trial show that pembrolizumab was safe and…
Crizotinib was the first drug licensed to treat ALK-positive non-small cell lung cancer (ALK NSCLC).…
A study of samples from patients with multiple myeloma (MM) has demonstrated how “reprogrammed” fat…
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
The incidence of early onset colorectal cancer has increased nearly 50 percent in the last…
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the…